Founder Story and Company Narrative: How to Tell Yours Without Overpromising

1. Blog
2. Strategy & Positioning

By Saroj Jha · October 5, 2026 · 12 min read

A good founder story explains why this problem, why your team and why now, and every claim in it matches what the company can show today. Write it once as a company narrative, then cut it for investors, customers, journalists and LinkedIn. The five steps below show how, with one example company.

Every founder already tells a story: in the pitch, on the website, in the first sales call. Most tell a slightly different version each time. A company narrative is the one version the team agrees on and writes down, so that investors, customers, journalists and new hires hear the same facts.

Research on entrepreneurship treats storytelling as more than decoration: stories help a new company look legitimate and win resources. It also warns that the same story can backfire when it promises more than the company delivers. This post covers both.

Running case: Example Co. Fictional

Example Co. is a seed-stage MedTech startup with a benchtop blood analyzer for outpatient clinics. From a fingerstick sample, it reports routine tests such as HbA1c (a common blood sugar test) and a lipid panel in about 12 minutes, so the clinician can discuss the results during the visit instead of waiting a day or two for an outside lab. In the case it is FDA-cleared and CLIA-waived (a US category for simple lab tests). It sells first to independent primary-care practices with 3 to 10 clinicians and has 12 clinics live. In the next quarter its two founders, one a former lab scientist, will meet investors, pitch healthcare trade journalists and start posting on LinkedIn. Today each founder tells the story differently. Example Co., its founders and all its numbers are illustrative.

Step 1: Know what a story does for a young company

A new company has no track record, so people judge it partly by the story it tells. Lounsbury and Glynn describe "cultural entrepreneurship" as the storytelling that links a founder's existing resources to the capital and opportunities they go on to win. In their framework, stories help craft a new venture identity that investors, competitors and consumers can recognize as legitimate^[4].

Martens, Jennings and Jennings tested the idea on real documents: the prospectuses of every initial public offering from 1996 to 2000 in three high-tech industries. They found narratives help a firm acquire resources in three ways: by giving it an identity people can understand, by explaining the logic of how it will exploit an opportunity, and by placing it within wider stories people already know. Their quantitative results tied these parts of the narrative to the resources firms acquired, beyond the factors earlier research had emphasized^[1].

Example Co., step 1 Fictional

The founders write one sentence for each job. Identity: "a benchtop blood analyzer that gives primary-care clinics results during the visit." Logic: "results during the visit let clinicians discuss them with patients then, so practices keep the analyzer and keep reordering cartridges." Context: "practices want faster answers for routine tests, and a small analyzer can now run them from a fingerstick." All fictional.

Do this

Write one sentence each for your identity, your logic and your context. If you cannot write the logic sentence, the story is not ready.

Free tool

Test your identity sentence

The free Positioning Statement Generator turns seven guided prompts into a positioning statement and an elevator pitch, and flags vague language before it reaches your story.

Step 2: Build one narrative spine

In my view, a usable company narrative has five parts, in this order:

1. Problem. Who has it and what it costs them, in their words.
2. Why us. What the founders know or have done that makes them likely to solve it.
3. Why now. What changed that makes a solution possible or urgent today.
4. Proof today. What is already true and checkable: customers, usage, results.
5. Where next. Where the company goes if the first part works.

The order matters. A founder story that starts with "I always wanted to start a company" is about the founder. One that starts with the problem is about the customer, and the founder earns a place in it through "why us".

Example Co., step 2 Fictional

The spine, in one line per part (fictional). Problem: clinics send routine bloodwork to an outside lab and wait a day or two, so results cannot be discussed during the visit. Why us: one founder spent years as a lab scientist running these tests. Why now: a fingerstick analyzer small enough for a clinic bench now runs routine tests in about 12 minutes. Proof today: 12 clinics are live and ordering cartridges. Where next: urgent care centers, then health-system outpatient clinics once there is published accuracy evidence.

Do this

Write your five parts on one page, one or two sentences each, and get every founder to agree to it before anyone pitches again.

Step 3: Separate what is true today from what you hope

Stories that look forward help win support, and they also create risk. Garud, Schildt and Lant call this the paradox of legitimacy: "the very expectations that are set through projective stories to gain venture legitimacy can also serve as the source of future disappointments." Because of uncertainties those stories mask, ventures "will likely deviate from their early projections, thereby disappointing stakeholders," which can cost them legitimacy^[5].

Investors also seem to reward substance over show. In a lab experiment and a field study of business plan presentations, Chen, Yao and Kotha found that venture capitalists' perception of an entrepreneur's preparedness, not their passion, positively affected decisions to fund^[6].

At the extreme, a story that outruns the facts is not just a marketing problem. When the SEC charged Theranos and its founder in 2018 with raising more than $700 million through false statements, Jina Choi, director of the SEC's San Francisco Regional Office, said: "The Theranos story is an important lesson for Silicon Valley. Innovators who seek to revolutionize and disrupt an industry must tell investors the truth about what their technology can do today, not just what they hope it might do someday"^[7].

For a medical product, modest claims also matter for a second reason. The FDA's rule on "intended uses" says the objective intent of the people responsible for a product's labeling "may, for example, be shown by labeling claims, advertising matter, or oral or written statements by such persons or their representatives"^[8]. So what a founder says about a medical product should match what it is cleared to do. Regulatory counsel can check where that line sits.

If you sell an AI product

In my view, an AI founder story needs this test more than most, because buyers can try the product and check a claim in the first trial. Three lines deserve a second look. "Why now" should say what your team can do that others cannot; a new model release is a "why now" every competitor can tell too. "Proof today" should say how often a person still steps in, if one does. And if the product runs on another company's model, say so plainly. The story should not imply you built what you license.

The SEC's 2025 order against Presto Automation, which sold an AI drive-thru ordering product called Presto Voice, shows why. The order says Presto claimed in registration statements that Presto Voice "eliminat[es] human order taking", while human order takers abroad "processed the vast majority of drive-thru orders placed through Presto Voice". It also says that, from at least November 2021 to September 2022, the voice AI technology in every deployed unit "was actually owned and operated by Supplier A"^[3]. Presto settled "without admitting or denying the findings herein". These are the SEC's findings in a settled order, not an account of how the company decided internally.

Example Co., step 3 Fictional

The founders go through their pitch line by line. "Our analyzer replaces the lab" becomes "our analyzer runs a few routine tests during the visit; an outside lab does the rest." "Proven to improve patient outcomes" becomes "we do not yet have outcome evidence; we are designing a study." "Trusted by clinics everywhere" becomes "12 independent practices use it today; health systems are a later goal." They also check each line against the analyzer's cleared use. All fictional.

Do this

Mark every sentence in your story as "true today" or "goal". Every goal needs the word "plan", "aim" or "next" in it. If your product is regulated, check each claim against what it is cleared for.

Step 4: Learn from narratives that real companies published

Two well-known companies show what a written company narrative can look like. These are what the documents say, not an account of how either company made its choices internally.

What Amazon's 1997 letter shows

Amazon's first letter to shareholders, written after its 1997 IPO, opens with results: "Amazon.com passed many milestones in 1997: by year-end, we had served more than 1.5 million customers, yielding 838% revenue growth to $147.8 million, and extended our market leadership despite aggressive competitive entry." It then frames the future: "But this is Day 1 for the Internet and, if we execute well, for Amazon.com"^[9].

Under the heading "It's All About the Long Term", it tells readers how to judge the company: "We first measure ourselves in terms of the metrics most indicative of our market leadership: customer and revenue growth, the degree to which our customers continue to purchase from us on a repeat basis, and the strength of our brand." And it explains why it is telling them: "Because of our emphasis on the long term, we may make decisions and weigh tradeoffs differently than some companies. Accordingly, we want to share with you our fundamental management and decision-making approach so that you, our shareholders, may confirm that it is consistent with your investment philosophy".

What I take from it: a narrative is stronger when it pairs a big frame with results to date, names the measures it wants to be judged by, and says how the company will behave.

What Butterfly Network's annual report shows

Butterfly Network, a maker of handheld ultrasound devices, is a MedTech company whose annual report on Form 10-K for the year ended 31 December 2020 puts a mission, a problem and a founder's record side by side. Its Business overview gives the mission: "We are an innovative digital health business with a mission of democratizing healthcare by making medical imaging accessible to everyone around the world." It states the problem in the buyer's terms: "Many healthcare institutions throughout the world lack the facilities and capital necessary to acquire and maintain expensive cart-based devices and cannot afford the highly trained individuals required to operate them." And it puts a price on the old alternative: "Traditional cart-based equipment typically ranges from $45,000 to $60,000 per new device in the mid-range and is required to be operated by trained healthcare professionals."

The same overview gives the founder's record as the reason to believe: "Legacy Butterfly was founded in 2011 by Dr. Jonathan Rothberg, a serial entrepreneur who received the Presidential Medal of Technology & Innovation in 2016 for inventing a novel next generation DNA sequencing method and has founded more than 10 healthcare/technology companies, including 454 Life Sciences, Ion Torrent and CuraGen"^[10]. This is what the filing says, not how the company decided internally.

In my view, the pattern is useful because the founder's record is stated as evidence for "why us", next to a problem with a price. A founder in a technical field can do the same with a real track record instead of a personal anecdote.

Example Co., step 4 Fictional

The founders borrow the pattern for a one-page letter on their website: results so far (12 clinics live), the frame (results during the visit, not two days later), how to judge them (clinics retained, cartridge reorders and, in time, published accuracy evidence), and how they will behave (they will not claim patient outcomes before they can show them, and they will check every claim against the analyzer's cleared use). The lab-scientist founder's years of running these tests carry "why us". All fictional.

Do this

Add two lines to your narrative: the measures you want to be judged by, and one commitment about how you will behave.

Step 5: Cut the narrative for each audience

The facts stay the same; the opening and the proof change.

• Investors. A survey of 885 venture capitalists found that "in selecting investments, VCs see the management team as more important than business related characteristics such as product or technology"^[2]. So "why us" and "proof today" lead.
• Customers. Lead with the problem in their words, then proof today. The founder's journey matters less than whether the product works for them.
• Journalists. Lead with "why now" and one fact they can check. My post on pitching a journalist covers the pitch itself.
• LinkedIn. One part of the spine per post, in the founder's own voice. The founder LinkedIn playbook covers the rhythm.
• New hires. Lead with the problem and where next.

Example Co., step 5 Fictional

The investor version opens with the founder who spent years as a lab scientist and the 12 live clinics. The practice-owner version opens with "Results during the visit, not two days later." The journalist pitch opens with why now: a fingerstick analyzer small enough for a clinic bench, used in independent primary-care practices. Each founder's LinkedIn posts take one part of the spine at a time. All fictional.

Do this

Write the first sentence of your story for each of the five audiences, and check that the facts behind each one are the same.

What changes by stage?

• Pre-seed — The story is mostly "problem", "why us" and "why now". Be honest that proof is still coming, and say what you will test first.
• Seed — Write the five-part spine down and share it with the whole team. Proof today should now include paying customers or real usage.
• Series A–B — Publish a fuller narrative, such as a founders' letter, with the measures you want to be judged by. Review it every year as the facts change.

What mistakes should I avoid?

• Starting with yourself. Start with the problem; the founder story earns its place through "why us".
• Stating goals as facts. Label everything that is not true yet.
• A different story for each audience. Change the opening, not the facts.
• Passion instead of preparation. One study of investor decisions found preparedness, not passion, made the difference.
• Claims beyond what a medical product is cleared to do. In medical products, spoken and written claims can be read as intended use.
• Never updating it. A narrative that no longer matches the company is a liability.